LAKE FOREST, Ill., July 12 /PRNewswire-FirstCall/ -- Hospira, Inc. , the independent company recently created from the core global hospital products business of Abbott Laboratories, announced today that it will release its 2004 second-quarter financial results on Tuesday, August 10, 2004, before the U.S. stock market opens. A conference call featuring remarks by senior management will be held with investors and the media that same day at 9 a.m. Central Time.
A live webcast of the conference call will be available online at http://www.hospira.com/ or through CCBN’s individual investor center at http://www.companyboardroom.com/ . Listeners should log on approximately 10 minutes in advance to ensure proper computer setup to receive the webcast. A replay will be available for 30 days following the call.
About Hospira
Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM) by developing, manufacturing and marketing products that help improve the safety and efficacy of patient care. Created from the core global hospital products business of Abbott Laboratories, Hospira is a new company with 70 years of service to the hospital industry. The company’s portfolio includes one of the industry’s broadest lines of generic acute-care injectables, integrated solutions for medication management and infusion therapy, and a full-service contract manufacturing business. Headquartered in Lake Forest, Ill., north of Chicago, Hospira has more than 14,000 employees and 15 manufacturing facilities worldwide. Hospira’s news releases and other information can be found at http://www.hospira.com/ .
Hospira, Inc.
CONTACT: Media, Stacey Eisen, +1-224-212-2276, or Financial Community,Lynn McHugh, +1-224-212-2363, both of Hospira, Inc.
Web site: http://www.hospira.com/
